The Hippo

HOME| ADVERTISING | CONTACT US|

Protein May Identify Deadlier Breast Cancer Concord NH

A protein linked to more aggressive and advanced breast cancer tumors has been identified by German researchers. The investigators analyzed 229 breast tissue samples from patients with cancer and compared them with healthy breast tissue. The study found that patients whose tumors had elevated levels of GLI1 (glioma-associated oncogene homolog 1) protein tended to have a more advanced stage of cancer, had an increased number of cancerous lymph nodes and a greater chance of death.

Hoke H Shirley III, MD
(603) 224-3368
264 Pleasant St
Concord, NH
Business
Concord Orthopaedic Professional Associates
Specialties
Rheumatology

Data Provided by:
Lake Side Animal Hospital
(603) 524-2553
552 Laconia Road
Tilton, NH

Data Provided by:
Jay Chester Smith
(603) 271-5300
36 Clinton St
Concord, NH
Specialty
Family Practice

Data Provided by:
Patrick Carroll
(603) 228-7400
250 Pleasant St
Concord, NH
Specialty
Family Practice

Data Provided by:
Joel Lowne
(603) 485-8441
250 Pleasant St
Concord, NH
Specialty
Family Practice

Data Provided by:
Clifford M Levy, MD
(603) 224-3368
264 Pleasant St
Concord, NH
Business
Concord Orthopaedic Professional Associates
Specialties
Orthopedics

Data Provided by:
Northside Animal Hospital
(603) 622-5299
574 Arah Street
Hooksett, NH

Data Provided by:
Russell S Kay
(603) 227-7000
250 Pleasant St
Concord, NH
Specialty
Family Practice, Emergency Medicine

Data Provided by:
Katherine Mary Brower
(603) 226-6113
253 Pleasant St
Concord, NH
Specialty
Internal Medicine

Data Provided by:
Gerard A Dillon
(603) 224-6070
246 Pleasant St.
Concord, NH
Specialty
Cardiology, Internal Medicine, Cardiovascular Disease

Data Provided by:
Data Provided by:

Protein May Identify Deadlier Breast Cancer

Provided By:

TUESDAY, Aug. 25 (HealthDay News) -- A protein linked to more aggressive and advanced breast cancer tumors has been identified by German researchers.

The investigators analyzed 229 breast tissue samples from patients with cancer and compared them with healthy breast tissue. The study found that patients whose tumors had elevated levels of GLI1 (glioma-associated oncogene homolog 1) protein tended to have a more advanced stage of cancer, had an increased number of cancerous lymph nodes and a greater chance of death.

GLI1 could be a useful measurement for determining cancer prognosis, according to the study published this week in the journal BMC Cancer.

"GLI1, a mediator of the so-called 'hedgehog' signaling pathway, has previously been implicated in the development of different human tumor entities," said lead study author Edgar Dahl of RWTH Aachen's University Hospital in Germany, in a news release from the journal's publisher.

"We've found a positive, significant association between overexpression of GLI1 and unfavorable overall survival outcome in human breast cancer," Dahl added.

Overexpression of GLI1 has also been implicated in esophageal cancer, the researchers noted.

"Taken together, these results support a role of GLI1 as a new prognostic biomarker in breast cancer," Dahl said. "Future studies will determine whether GLI1 can be successfully included into multimarker panels for early cancer detection or molecular sub-typing of breast cancer. This could support personalized breast cancer medicine."

More information

The American Cancer Society has more on breast cancer.

SOURCE: BioMed Central, news release, Aug. 24, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

®2010 Hippo Press. site by wedu